The MAD7™ Nuclease
News & Events
Digital genome engineering
December 22, 2020
Helping to Hasten the Groundbreaking SynBio Sc2.0 Project
How much can we learn about biology by building a synthetic eukaryotic genome from scratch, one chromosome at a time? An ambitious group of…
December 15, 2020
University of Edinburgh Scientists Demonstrate Value of Open-Source MAD7 Enzyme
Here at Inscripta, our vision for expanding access to digital genome engineering has always been broader than developing an automated benchtop…
December 8, 2020
Inside Inscripta: Beth Vitalis, Biosecurity
Our “Inside Inscripta” blog series allows readers to get to know the terrific people who make up our company.
December 3, 2020
McKinsey Report: Bioeconomy to Drive $4 Trillion Globally
We are not the only ones excited about the potential for a bio-driven economy. A report from analysts at the McKinsey Global Institute called…
December 1, 2020
We Won! Onyx™ Platform Named to The Scientist’s Top 10 Innovations for 2020
For developers of a brand new technology platform, it doesn’t get much better than this: we are delighted to report that independent judges for…
November 24, 2020
How to Improve Target Discovery with Genome-Scale Engineering
Identifying and validating key variants associated with desired traits is hard work. Really hard work.
November 17, 2020
Technology Networks: CRISPR Needs to Scale. Now.
Even the biggest fans of CRISPR have to acknowledge that the gene editing technique is not the easiest to use. (“Temperamental,” “tedious,” and…
November 13, 2020
With BioMADE, Inscripta Will Contribute to Bio-Based Manufacturing Innovation
The Inscripta team is very proud to announce that we are part of a large network selected by the U.S. Department of Defense to establish a new…
November 10, 2020
Our History: A Look at the CREATE Technology
While the Inscripta team’s default setting is to look forward — with a keen focus on the digital genome engineering future we aim to build —…
2 of 3
to meet the future with Digital Genome Engineering.